Metropolitan Life Insurance Company (MetLife)’s Constellium CSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,029
Closed -$155K 518
2024
Q1
$155K Sell
7,029
-266
-4% -$5.15K 0.01% 818
2023
Q4
$146K Hold
7,295
0.01% 891
2023
Q3
$133K Buy
7,295
+352
+5% +$6.21K 0.01% 874
2023
Q2
$119K Buy
+6,943
New +$107K 0.01% 926
2023
Q1
Sell
-7,766
Closed -$91.9K 2347
2022
Q4
$91.9K Hold
7,766
﹤0.01% 1098
2022
Q3
$78.7K Hold
7,766
﹤0.01% 1163
2022
Q2
$103K Hold
7,766
﹤0.01% 1039
2022
Q1
$140K Sell
7,766
-23,663
-75% -$432K 0.01% 995
2021
Q4
$563K Hold
31,429
0.01% 1344
2021
Q3
$590K Buy
+31,429
New +$605K 0.01% 1346

Other funds holding CSTM

Metropolitan Life Insurance Company (MetLife)'s CSTM Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Constellium (CSTM) in Q2 2024, closing a stake of 7,029 shares — an estimated $155K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CSTM in Q3 2021 and held it in 10 quarters. The position peaked at $590K in Q3 2021. 224 funds tracked by Wall St. Rank hold CSTM as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Constellium position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 7,029 Constellium shares in Q2 2024, an estimated $155K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Constellium in Q3 2021 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Constellium position peaked at $590K in Q3 2021.
  • 224 funds tracked by Wall St. Rank held Constellium as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.